- Our Company
- News & Events
- Contact Us
The quick turnaround time of the Guardant360® liquid biopsy test allows for shorter time to treatment for patients with advanced stage cancer compared to tissue biopsies.
Guardant360 test results are delivered to physicians in seven days upon sample receipt in the laboratory and this allows physicians to see the current genomic profile of the patient’s tumor and recommend appropriate treatment.
Visit us at www.guardanthealthamea.com to find out more about the Guardant360® test and how it can help to guide treatment decisions for patients with advanced stage cancer.
#guardanthealth #guardanthealthamea #guardant360 #liquidbiopsy #comprehensivegenomicprofiling